Hilvo M, Witoslawska A, Laaperi M, Jylha A, et al. Ceramide-phospholipid risk score associates with cardiovascular events and is lowered by atorvastatin, simvastatin and anti-PCSK9 treatments. J Cardiovasc Pharmacol 2026 Mar 12. doi: 10.1097/FJC.0000000000001817.
PMID: 42429171